Issue 22, 2014

Toxicity of high glycolic poly(dl-lactic-co-glycolic acid) stabilized ruthenium nanoparticles against human promyelocytic leukemia cells

Abstract

High glycolic poly-(lactic-co-glycolic acid) stabilized ruthenium nanoparticles were toxic towards human promyelocytic leukemia cells (HL60) and the mode of cell death was by apoptosis and in contrast it was not toxic towards blood lymphocytes. There was a significant increase in the oxidative stress within these cells and the toxicity of nanoparticles towards HL 60 cells could be attributed to the TGF β mediated signal transduction. This study indicated that such polymer stabilized ruthenium nanoparticles could be used as a selective anticancer agent.

Graphical abstract: Toxicity of high glycolic poly(dl-lactic-co-glycolic acid) stabilized ruthenium nanoparticles against human promyelocytic leukemia cells

Supplementary files

Article information

Article type
Paper
Submitted
29 Nov 2013
Accepted
13 Jan 2014
First published
14 Jan 2014

RSC Adv., 2014,4, 11438-11443

Toxicity of high glycolic poly(DL-lactic-co-glycolic acid) stabilized ruthenium nanoparticles against human promyelocytic leukemia cells

V. Nandakumar, V. Vettriselvi and M. Doble, RSC Adv., 2014, 4, 11438 DOI: 10.1039/C3RA47142J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements